Dilution profile // every instrument, one screen, from SEC filings

IRIDEX CORP (IRIX)

CIK 1006045 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed sub-ratings (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
HIGHS-3 on file 2024-09-05
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
LOWwarrants = 3% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
LOW+8% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
LOW~26.6 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2020-10-222026-08-13

Latest: 17.6M shares as of Aug 13, 2026 (10-Q).

⊙
EVIDENCE — filed/published fact
SourceSEC XBRL, cover-page share count
Fielddei:EntityCommonStockSharesOutstanding
As of2026-08-13
HowThe newest cover-page count as filed, whatever its age. The float checker applies a 200-day freshness rule and sets this beside the balance-sheet count.
Open the source document →

Cash runway

Self-funding

generates cash

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 600,000 underlying shares, as reported Aug 31, 2007 (10-K).

Reported exercise price: $0.01 (aggregate figure as tagged; individual tranches vary).

Rough fully diluted estimate: 18.2M = 17.6M O/S + 600,000 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

NotePrincipalCarryingConv. priceRateIf converted
Novel Notes$4.0M—$0.21—~19.0M sh

If every note above converted at its tagged price: ~19.0M new shares on 17.6M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.

Notes exactly as the company dimensioned them in its 10-Q filed Aug 18, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding17.6MAug 13, 2026
+ Warrants (aggregate, as tagged) (if exercised)600,000Aug 31, 2007
+ Novel Notes (if fully converted)19.0MMar 19, 2025
Fully diluted estimate37.2M+111.9% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

S-3Sep 5, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 0 executed · 0 registered.

EXECUTEDMar 20, 2025Unregistered share sale disclosed (8-K item 3.02)8-K →
UPDATESep 25, 2024Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVESep 24, 2024SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDSep 5, 2024S-3 registration — capacity to sell shares, not a sale yetS-3 →
EXECUTEDAug 5, 2024Unregistered share sale disclosed (8-K item 3.02)8-K →
UPDATEJul 27, 2021Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEJul 27, 2021SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDJul 9, 2021S-3 registration — capacity to sell shares, not a sale yetS-3 →
EXECUTEDSep 14, 2018Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EXECUTEDSep 13, 2018Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EXECUTEDDec 9, 2016Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
EXECUTEDDec 9, 2016Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full IRIX workspace